← Evidence map

ArticleHeliyon2020

Severe CIDP-MGUS responsive to Rituximab.

Andreas Posa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

4 papers cite it

2020
2021
2022
2023
2024
2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 32596526